ViaCyte is a series c plus startup based in United States. 1 investor tracked. Status: zombie.
ViaCyte is a startup founded in 1999 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
ViaCyte is a regenerative medicine company focused on developing cell replacement therapies for diabetes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.